FDA Convenes Panel To Review Drug-Associated Suicidality Study
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA joint committee meets July 10 to consider results of placebo-controlled trials of 11 drugs, including Lamictal, Carbatrol and Lyrica.
You may also be interested in...
Vivus’ Qnexa Combo For Obesity Needs FDA ‘Persuasion’ To Take First-Line In Diabetes
CEO hails positive Phase III data, but not all analysts are convinced.
Vivus’ Qnexa Combo For Obesity Needs FDA ‘Persuasion’ To Take First-Line In Diabetes
CEO hails positive Phase III data, but not all analysts are convinced.
FDA Panel To Review Ovation’s Sabril For Dual Epilepsy Indications
Vigabatrin set for review by Peripheral and Central Nervous System Drugs panel for seizures in adults and infantile spasms Aug. 6-7.